Abstract Number: 2574 • ACR/ARHP Annual Meeting 2016
IL-22 As a Biomarker for Erosive Disease in Rheumatoid Arthritis
Background/Purpose: Consistent with models of experimental arthritis implicating IL-22 – in the development of joint destruction could previously demonstrate that elevated IL-22 serum levels were…Abstract Number: 1532 • ACR/ARHP Annual Meeting 2015
Occurrence of Valvular Heart Disease in Rheumatoid Arthritis: A Population Based Study
Background/Purpose: Patients with rheumatoid arthritis (RA) are known to have an increased risk of cardiovascular disease, particularly atherosclerosis and heart failure. However, little is known…Abstract Number: 1557 • ACR/ARHP Annual Meeting 2015
The Impact of Hindfoot Deformity on Disability of Korean Patients with Rheumatoid Arthritis
Background/Purpose: Rheumatoid arthritis (RA) commonly involves the hindfoot, but this part is frequently overlooked when caring for patients with multiple joints pain and deformity. For…Abstract Number: 1630 • ACR/ARHP Annual Meeting 2015
Progressive Destruction of Large Joints in Patients with Rheumatoid Arthritis Treated with Biologic Agents
Background/Purpose: Many clinical trials have revealed that biologic agents inhibit destruction of small joints, however, there have been a few reports demonstrating their inhibitory effects…Abstract Number: 1841 • ACR/ARHP Annual Meeting 2014
Eventual Joint Failure and Surgery Rates in Rheumatoid Arthritis Remain High in Patients with Moderate Disease Activity in the First 5 Years of Disease
Background/Purpose: It is well-established that sustained high disease activity in RA results in worse outcomes. In reality many patients remain in low/moderate disease activity states,…Abstract Number: 90 • ACR/ARHP Annual Meeting 2014
Genetic Variants in IL-6, IL-10, C5-TRAF1 and FCRL3 and Progression of Joint Damage in Rheumatoid Arthritis; A Study on Six Cohorts
Background/Purpose Understanding the mechanisms underlying the inter-individual differences in radiographic progression is relevant and heritability studies have shown that genetic factors explain part of these…Abstract Number: 2259 • ACR/ARHP Annual Meeting 2013
Does a Ratingen Score Of ≥ 3 At Disease Onset Define RA In ACR/EULAR 2010 Criteria Negative Patients?
Background/Purpose: A EULAR task force has recently selected an evidence and consensus based definition of erosive disease defining rheumatoid arthritis (RA) in patients who do…Abstract Number: 2660 • ACR/ARHP Annual Meeting 2012
Progressive Radiographic Joint Damage in Established Rheumatoid Arthritis: Common and Strongly Associated with Seropositivity
Background/Purpose: During the last decade, rheumatoid arthritis (RA) research has mainly focused on early disease, as it has become apparent that early and aggressive treatment…Abstract Number: 1009 • ACR/ARHP Annual Meeting 2012
A New Approach for Detecting Progressive Joint Damage Using 3D Imaging From High-Resolution Peripheral Quantitative Computed Tomography: Measuring Reproducibility
A New Approach for Detecting Progressive Joint Damage using 3D Imaging from High-Resolution Peripheral Quantitative Computed Tomography: Measuring Reproducibility Background/Purpose: Joint space narrowing is an…
ACR Meeting Abstracts